Major foreign-invested pharmaceutical firms expanding presence in Korea

Published: 2007-02-21 07:00:00

Updated: 2007-02-21 07:00:00

This year, thee major multinational drug makers Pfizer Korea, GlaxoSmithKline and Sanofi-Aventis, are poised to expand their presence in the domestic market with their new brand items.

1) Pfizer Korea

The annual sales of Pfizer Korea had been gradually on the rise; 226.8 billion won in 200...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK